FDA issued a Warning Letter to Neurolumen LLC on 5/30/2014 as a result of this inspection.
FDA investigators audited the Neurolumen - Oklahoma City, OK, United States facility and issued 11 inspectional observations (via FDA 483) on 13 Dec 2013.
Add To Cart
- Category: Medical Devices & Rad Health
- Number of Observations: 11
- Inspection end: 13 Dec 2013
- Location: Oklahoma City, United States
- FEI: 3010144038